Skip to content

Flowers Foods stock

FLONYSE

Flowers Foods, Inc., Consumer DefensiveISIN US3434981011

$6.01▼ $0.24 (−3.8%)Closing price of 12 Nov 2026

42Score 42 out of 100, Weak

Turn on early warning

Price and trend

34 / 100

Price history

−48% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 23% below it.

Trend change

Since July 2024 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 47).

Distance to the high

The price is 50% below its 52-week high. Largest decline in 20 years: 82% (December 2022 to September 2026).

Chart figures for advanced users
SMA 50$6.10
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$7.81
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)47
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDbelow the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$5.55
The lowest closing price of the last twelve months.
Resistance$11.96
The highest closing price of the last twelve months.
Market cap
$1.27B
Div. yield
8.32%
12 months
42.6
includes one-off items, adjusted 7.3
8.5
on earnings for the next twelve months ($0.71 per share)
Fair value
$7.93

Snapshot

Computed from the data by fixed rules, no AI

  • Flowers Foods, Inc. belongs to the Packaged Foods industry (United States) and, with a market value of $1.27B, is number 57 of 76 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $5.26B (up 3% year on year) and earnings of $83.83M (down 66.2%).
  • For fiscal 2026, analysts expect on average revenue of $5.09B (down 3.2%) and adjusted earnings per share of $0.78 (down 29.2%).
Show more
  • MEQIRI Score 42 out of 100 (Weak): rank 276 of 296 in Consumer Defensive, median 62.
  • Our model puts fair value at $7.93, with the price 24% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings turn into cashFree cash flow above 500% of earnings over the last 12 months.Fundamentals 73
  • High dividend yieldDividend yield 8.32%, Packaged Foods median 3.53%.
  • Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 73

Weaknesses

  • Margin fallingOperating margin 3.3%, average of the prior years 6.8% (to 2024).Profitability 29
  • Share price fell sharplyDown 48% over the last 12 months.Momentum 27
  • Analysts expect falling earningsDown 5.7% a year through 2029 (estimates from 3 analysts).Growth 27
42/ 100
MEQIRI Score
Weak

Its standout strengths are valuation and fundamentals, while growth and momentum hold the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 46 to 42.

Fundamentals are strong, with stable profits.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)not measured
ROIC (12 months)2.1%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price far below its 52-week high

What lowers it

  • price not overheated over the past year

Valuation

Valuation signal

Modestly undervalued
Price
$6.01
Fair value
$7.93
Gap to fair value
−24%

In our model the price counts as cheap below $5.66 and expensive above $13.21 (uncertainty high, based on the price swings of the past year).

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $6.71, at 7.8% it would be $9.74.

Valuation metrics

32.56
11.1
Fair value (model)
$7.93

From the cash-flow model alone; the profit includes one-off items, so there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 10 Oct 2026, revenue rose 0.6% on the twelve months before. Revenue has grown solidly since 2006, at about 6% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 49%, operating 3%, net 2%.

Debt & balance sheet

latest quarter
1.53
2.5x
0.11
Cash & equivalents
$72.25M

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
11 Feb 2027in 90 days
Last reported
12 Nov 2026EPS reported $0.10 (expected $0.15)below expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20274 analysts
Earnings per share
$0.78−0.4%
Revenue
$5.09B0.0%
Fiscal 20284 analysts
Earnings per share
$0.70−1.4%
Revenue
$5.08B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook lowered

Share price after the results: +2.5%

The second quarter missed expectations and sales are expected to fall year on year in the third quarter; the updated full-year guidance requires an improvement in the second half.

Supporting passage from the call, verbatim
“I mean if I think about the implied performance in your updated guidance for the back half, even at the low end, it seems to imply some acceleration and some improvement certainly versus the exit rate of consumption that we saw coming out of 2Q.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 21 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

One insider bought on the open market in the last 6 months, $37,542 in total. One insider sold, $25,937 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Cox CindySale

    8 Oct 2026, Chief Human Resources Officer

    Shares
    4,400
    Price
    $5.89
    Value
    $25,937
  • Scaglione Diego AnthonyPurchase

    8 Jun 2026, Chief Financial Officer

    Shares
    5,000
    Price
    $7.51
    Value
    $37,542

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Flowers Foods

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

296 rated companies in Consumer Defensive

Rank 276 of 296
276/ 296
This company
42
Sector median
62

Categories against the sector median

ProfitabilityMedian of 296 companies29 (median 54)25 below the median
GrowthMedian of 296 companies27 (median 50)23 below the median
FundamentalsMedian of 296 companies73 (median 79)6 below the median
ValuationMedian of 291 companies with a value77 (median 65)12 above the median
StabilityMedian of 296 companies36 (median 68)32 below the median
Capital allocationMedian of 296 companies41 (median 62)21 below the median
Technical analysisMedian of 296 companies34 (median 64)30 below the median
MomentumMedian of 296 companies27 (median 59)32 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Packaged Foods

The next larger and next smaller companies by market value

All 76 Packaged Foods stocks

ETFs that hold Flowers Foods

Held by 12 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
iShares S&P SmallCap 600 UCITS ETFIUS30.07%0.30%€2.31B
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV0.06%0.30%€964.08M
Xtrackers Russell 2000 UCITS ETF 1CXRS20.04%0.30%€2.22B
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 3 Jan 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 27 Feb 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy